Hospital-acquired infections touch 1 in 25 patients. That was the original CDC estimate that put HAIs on the map. The more current picture is not that positive as well. On any given day in 2023, about 1 in 38 hospitalized patients had at least one healthcare-associated infection. Progress is being made, yes. But the numbers are still staggering.
In American hospitals alone, the CDC estimates that HAIs account for an estimated 1.7 million infections and 99,000 associated deaths each year. And the transmission pathways are often hiding in plain sight. Contaminated surfaces, insufficient handwashing and PPE, and lack of protection from airborne pathogens are significant factors in the spread of HAIs.
One material choice could protect thousands. This blog gives you the framework to make that decision with confidence and make your healthcare facility a safer, and cleaner place that minimizes transmission risk.
You may not think of material specifications as a front-line infection control measure. Most procurement teams do not. But the surface material of your medical equipment is in direct contact with patients, staff, and clinical environments around the clock.
Contamination of the inert hospital environment, healthcare workers, and medical equipment facilitates the rapid spreading of hospital microorganisms from patient to patient, from healthcare worker to patients, and from inanimate surfaces to all bodies. That is not a theoretical risk but a scientifically documented transmission path.
Non-invasive portable clinical items shared among patients are part of the patient's immediate surroundings and may pose a threat of pathogen transmission. Microorganisms can live on these items' surfaces for long periods, with the microorganisms' life spans depending in part on the material of the surface, the ambient air temperature, and humidity.
That is why your material specification decisions sit squarely in compliance territory. The right surface material is not just a clinical preference. It is a risk management tool.
Thermoplastic polyurethane, or TPU film, is one of the most widely used polymer families in the medical device industry. TPU is well known and specified in the medical industry for medical devices and healthcare products, due to its excellent mechanical properties and biocompatibilities. It is flexible yet durable, resistant to abrasion, and capable of withstanding repeated cleaning and sterilization cycles.
The "antimicrobial" term is not a marketing term, it highlights a real benefit. It refers to specific additives incorporated into the polymer matrix during manufacturing. These agents work actively and inhibit bacterial growth on the surface of the material itself.
Biocompatible TPU film for healthcare facilities is used across a broad range of medical devices: catheters, flexible tubing, wearable patient monitors, equipment housings, and orthopedic components. Each of these applications comes with distinct performance and compliance requirements.
The three most clinically relevant antimicrobial agent types incorporated into medical grade antimicrobial TPU film are silver ion, zinc pyrithione (ZnPT), and polyhexamethylene biguanide (PHMB). Each has a distinct mechanism of action, a distinct efficacy profile, and a distinct risk consideration you need to weigh.
Silver ion is among the most established and widely studied antimicrobial agents used in medical polymer applications. Silver ions interact with four main components in bacterial cells: the cell wall, plasma membrane, bacterial DNA, and proteins involved in vital cellular processes such as the electron transport chain. Silver ions cause the degradation of the peptidoglycan cell wall and cell lysis, preventing bacterial propagation. These ions penetrate to the cell interior, where they bind to DNA bases. As a result, DNA loses its replication ability, thereby preventing bacterial reproduction.
What makes silver ion particularly valuable in medical TPU is its sustained-release behavior. The slower release of silver ions helps to prevent rapid depletion of the material. Such a slow and continuous release of silver ions, due to the adhesion forces between coatings and substrates, ensures a lasting antibacterial performance.
That durability matters for long-duration applications. Equipment like catheters, semi-permanent tubing, and implantable or near-implantable components cannot be surface-cleaned on a very frequent basis.
What to watch for: Silver ion-based formulations carry real benefits, but they are expensive. The raw material cost is higher than other antimicrobial agents, and there are documented environmental concerns around silver nanoparticle accumulation in aquatic ecosystems. These are not reasons to avoid silver ion TPU. They are reasons to apply it precisely where its long-lasting mechanism is genuinely needed. If that kind of safety is not required
Best suited for: Catheters, long-duration tubing, implantable-adjacent, and semi-permanent device components.
Zinc pyrithione operates differently. Where silver ions interfere with bacterial cellular processes over time, ZnPT disrupts the microbial cell wall more directly. Zinc and copper pyrithione are useful as antimicrobial agents active against gram-positive and negative bacteria, fungi, and yeasts.
Testing in thermoplastic elastomers, which are closely related to TPU in composition, has demonstrated impressive pathogen reduction performance. Samples prepared with ZnPT eliminated 99.9% of the E. coli and 99.7% of the S. aureus population. Staphylococcus aureus and Pseudomonas aeruginosa are two of the most common and most dangerous pathogens found on contaminated hospital equipment surfaces.
What to watch for: ZnPT is not the right decision for wound-adjacent or highly tissue-intimate applications. Its characteristics are better matched to equipment exterior surfaces protection than to patient-contact materials with direct skin or mucous membrane exposure.
Best suited for: Equipment housings, diagnostic device exteriors, high-touch portable clinical equipment.
PHMB is the quieter specialist of the three. Less talked about in procurement circles than silver, but its effectiveness is clinically well-established. Polyhexamethylene biguanide is a broad-spectrum antiseptic that lacks many efficacy and toxicity problems associated with antimicrobials.
So how does it get rid of bacteria? Its eradication mechanism is membrane-targeted. PHMB exerts bactericidal effects through membrane disruption via electrostatic interaction. That chemical action causes cytoplasmic leakage and cell death within 5 to 10 minutes of contact.
The safety profile is well-documented and reassuring. In concentrations up to 0.3%, PHMB has been described as "practically non-toxic," with good cell and tissue tolerability and a very low risk of sensitisation. That tolerability makes it a strong candidate for patient-contact surfaces.
What to watch for: PHMB is highly suitable for surface contact and short-to-medium duration contact applications. For long-term implantable use, your biocompatibility testing requirements will need to cover the full ISO 10993 evaluation series, and PHMB should not be assumed compliant without documented testing at the intended concentration and device category.
Best suited for: Wound-adjacent surfaces, patient-contact exteriors, post-operative environment equipment, wearable monitors.
Getting the antimicrobial agent right is only part of the specification. The compliance framework governing biocompatible TPU for healthcare facilities is layered, and the film also needs to fulfill quality standards in addition to having the right material formulation. One of the most common procurement errors is to source antimicrobial films that do not meet medical grade certifications.
Here are the four pillars you need to be clear on.
This is the international reference standard for biocompatibility evaluation of medical devices. The ISO 10993-1 standard divides medical devices into three main categories: surface devices, externally communicating devices, and implant devices. Each category is further divided into subcategories according to the type of contact to which the patient is exposed. ISO 10993 further breaks these categories into subcategories based on exposure time: limited, prolonged, and permanent.
Why does this matter for your procurement decision? Because the biocompatibility testing required for a catheter material is categorically different from what is required for an equipment housing. Knowing your device category before you source your TPU is not optional. It determines which ISO 10993 sub-standards apply.
USP Class VI is widely understood, frequently cited, and regularly misapplied. USP Class VI plastic testing is commonly used by manufacturers to classify materials, but it is not a replacement for ISO 10993 biocompatibility testing. While it is possible a USP Class VI material could also be ISO 10993 compliant, it is not a given. USP Class VI alone is not sufficient for adherence to ISO 10993.
Think of USP Class VI as the baseline requirement. USP Class VI focuses on material safety, while ISO 10993 evaluates the final medical device under real-use conditions. Both matter.
The European Medical Device Regulation (MDR 2017/745) and the US FDA mandate clinically proven biocompatible materials for all products that come into contact with the medical device body. For manufacturers, this means: no market approval without documented biocompatibility testing.
Your supplier should hold relevant FDA 21 CFR compliance documentation and, if your healthcare equipment is to be used in EU markets, EU MDR alignment. Request these documents before committing to a supplier, not after.
This is where compliance managers earn their value. Knowing the standards is one thing. Knowing what paperwork validates them is another. Before finalizing any hospital-grade antimicrobial materials for equipment, request the following from your TPU supplier:
ISO 10993 test reports relevant to your specific device category and exposure subcategory:
Certificate of Conformance (CoC) with batch-level traceability
Sterilization compatibility data: gamma irradiation, ethylene oxide (EtO), and autoclave resilience as applicable
FDA 21 CFR material compliance letter or EU MDR technical file reference, depending on your target market
Do not accept a supplier's verbal assurance that a material is "medical grade." Ask for the documentation. Then read it.
The following checklist is designed for procurement professionals and compliance managers who need a structured, risk-aware process for evaluating and sourcing antimicrobial TPU for medical equipment. Work through it sequentially. Do not skip the documentation steps.
Identify whether your application falls under surface device, external communicating device, or implant device per ISO 10993-1
Determine exposure duration. This can be subdivided into three categories namely, limited (under 24 hours), prolonged (24 hours to 30 days), or permanent (over 30 days)
Remember to document this classification before approaching any supplier
Match your device category and clinical environment to the appropriate antimicrobial agent discussed in this blog
Next, consider the kind of exposure the hospital environment is capable of: does your environment require antibacterial only, or antifungal coverage as well?
This includes confirming the following documentation proof
ISO 10993 test reports specific to your device category
USP Class VI certification
Certificate of Conformance with batch-level traceability
Sterilization compatibility data for your intended sterilization method
FDA 21 CFR or EU MDR compliance documentation as required by your market
This step involves verifying if the antimicrobial agent concentration is appropriate for the intended application. You need to confirm compatibility with your internal cleaning and disinfection protocols. That means assessing mechanical performance data like flex fatigue, tensile strength, abrasion resistance etc.
Consider the total exposure environment. Do not just look at final price.
Factor in HAC program implications: a lower-grade material that contributes to HAI rates carries regulatory and financial consequences that far exceed any upfront material savings
The selection of antimicrobial TPU for medical equipment is not just a procurement decision. It is also intercnnected with clinical safety issue and linked with healthcare facility regulatory compliance. The wrong material in the wrong application does not just underperform. It creates liability, infection risk, nd patient harm.
Silver ion, zinc pyrithione, and PHMB each serve different purposes with different strengths. Know which one belongs in your equipment specification, know which compliance standards apply to that application, and know what documentation your supplier needs to provide before you approve a material.
Your next step is easy. Review your current equipment material specifications against the framework in this guide. Identify any gaps between what you have and what ISO 10993 and your device category require. Then schedule a material review with a certified medical grade antimicrobial TPU supplier and request the full documentation package before any sourcing decision is made.
Hospital-acquired infections touch 1 in 25 patients. That was th
READ FULLIf you are looking to source TPE film from a market that combines technical rigor with industrial
READ FULLIn a packaging, manufacturing, or product design career, material decisions are important. TPE an
READ FULL
